Nurix Therapeutics (NRIX) Cash from Operations (QoQ) (2020 - 2026)
Nurix Therapeutics (NRIX) Cash from Operations (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Nurix Therapeutics | 2.64 Bn | 2.19 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -34.29% |
| Feb 28, 2026 | -6.02% |
| Nov 30, 2025 | -18.21% |
| Aug 31, 2025 | 9.14% |
| May 31, 2025 | -3.40% |
| Feb 28, 2025 | -25.30% |
| Nov 30, 2024 | -15.59% |
| Aug 31, 2024 | -6.23% |
| May 31, 2024 | 5.35% |
| Feb 29, 2024 | -257.18% |
| Nov 30, 2023 | 164.88% |
| Aug 31, 2023 | -122.71% |
| May 31, 2023 | 61.88% |
| Feb 28, 2023 | -27.66% |
| Nov 30, 2022 | 18.04% |
| Aug 31, 2022 | -40.69% |
| May 31, 2022 | 22.79% |
| Feb 28, 2022 | -37.91% |
| Nov 30, 2021 | -3.13% |
| Aug 31, 2021 | 4.96% |